Systematic review with meta-analysis: effectiveness of direct-acting antiviral treatment for hepatitis C in patients with hepatocellular carcinoma.
Sichan HeIan LockartMaryam AlaviThomas BergBehzad HajarizadehGregory J DorePublished in: Alimentary pharmacology & therapeutics (2019)
Response to DAA therapy was lower in patients with HCC compared to those without HCC, regardless of cirrhosis status. Among HCC patients, there was an impact of proportion with curative HCC management on DAA therapy response.